MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,378,661 | -29.5% | 98,457 | +11.5% | 0.00% | 0.0% |
| Q2 2023 | $20,395,221 | +57.5% | 88,291 | +65.2% | 0.00% | 0.0% |
| Q1 2023 | $12,947,000 | +81858.6% | 53,442 | -1.8% | 0.00% | 0.0% |
| Q4 2022 | $15,797 | -99.3% | 54,426 | +49.8% | 0.00% | – |
| Q3 2022 | $2,361,000 | -17.1% | 36,332 | -8.7% | 0.00% | – |
| Q2 2022 | $2,849,000 | -18.6% | 39,799 | +11.6% | 0.00% | – |
| Q1 2022 | $3,500,000 | +19.2% | 35,674 | +2.9% | 0.00% | – |
| Q4 2021 | $2,936,000 | +2.5% | 34,657 | -3.5% | 0.00% | – |
| Q3 2021 | $2,865,000 | +294.1% | 35,908 | +381.5% | 0.00% | – |
| Q2 2021 | $727,000 | +14.1% | 7,457 | +37.1% | 0.00% | – |
| Q1 2021 | $637,000 | +44.1% | 5,441 | +37.0% | 0.00% | – |
| Q4 2020 | $442,000 | +13.6% | 3,972 | +21.8% | 0.00% | – |
| Q3 2020 | $389,000 | +16.5% | 3,261 | +10.4% | 0.00% | – |
| Q2 2020 | $334,000 | +71.3% | 2,953 | +1.3% | 0.00% | – |
| Q1 2020 | $195,000 | -15.6% | 2,916 | +14.9% | 0.00% | – |
| Q4 2019 | $231,000 | +4.5% | 2,538 | -0.9% | 0.00% | – |
| Q3 2019 | $221,000 | +2.3% | 2,562 | +19.4% | 0.00% | – |
| Q2 2019 | $216,000 | +2.4% | 2,146 | +27.4% | 0.00% | – |
| Q1 2019 | $211,000 | -99.5% | 1,685 | -99.6% | 0.00% | -100.0% |
| Q4 2018 | $44,017,000 | +11959.5% | 390,495 | +22776.1% | 0.01% | – |
| Q3 2018 | $365,000 | -93.5% | 1,707 | -91.5% | 0.00% | -100.0% |
| Q2 2018 | $5,630,000 | +37.5% | 20,129 | -42.6% | 0.00% | 0.0% |
| Q1 2018 | $4,094,000 | +4398.9% | 35,051 | +3419.2% | 0.00% | – |
| Q4 2017 | $91,000 | -72.0% | 996 | -85.8% | 0.00% | – |
| Q3 2017 | $325,000 | +622.2% | 7,027 | +141.7% | 0.00% | – |
| Q1 2017 | $45,000 | +45.2% | 2,907 | +39.2% | 0.00% | – |
| Q4 2016 | $31,000 | +3000.0% | 2,088 | +2272.7% | 0.00% | – |
| Q3 2016 | $1,000 | – | 88 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |